AgeneBio leadership presents at American Society for Experimental Neurotherapeutics Annual Meeting

AGB101 for the treatment of neuropsychiatric symptoms in Parkinson’s disease Presenter: Arnold Bakker, Ph.D., Johns Hopkins University Abstract Authors: Arnold Bakker, Gregory Pontone, Richard Mohs, Michela Gallagher Poster Presentation Hippocampal hyperactivity is a pathological hallmark of Alzheimer’s disease (AD) and a prognostic indicator of AD progression and clinical cognitive worsening in amnestic mild cognitive impairment…